The trial compared injectable semaglutide (1mg) once weekly with a placebo as an adjunct to the standard of care for the prevention of major kidney outcomes, specifically kidney failure, substantial loss of kidney function, and death from kidney or cardiovascular causes
There is a chronic form of the condition characterized by hairs that remain in the resting phase for a longer period, but shedding related to weight loss is typically more a sign of acute telogen effluvium
Semaglutide is safe and well-tolerated, but as we discussed earlier, there may be some side effects
10.3390/ijms141121513 106
Some patients who consistently eat smaller meals over extended periods may experience what could be described as stomach adaptation
Toll-like receptor 7 (TLR7)-driven accumulation of a novel CD11c + B-cell population is important for the development of autoimmunity